by Others
by AYUR
by AYUR
by Others
by Others
by Others
by Others
by Others
Composition:
ALBENDAZOLE-400MG
Uses:
Parasitic worm infections
Medicinal Benefits:
Rediout Chewable Tablet 1's belongs to a group of medicines called anthelmintic used to treat worm infections such as neurocysticercosis (infection caused by pork tapeworm) and cystic hydatid disease (infection caused by dog tapeworm). Rediout Chewable Tablet 1's is also used to treat infections caused by roundworms, hookworms, threadworms, whipworms, pinworms, flukes, and other parasites. Rediout Chewable Tablet 1's is a broad-spectrum anthelmintic drug which is highly effective against a wide range of intestinal helminths, including cestodes, nematodes, and trematodes. It is also effective against tissue helminth infections like cutaneous larva migrans (parasitic skin infections). Rediout Chewable Tablet 1's exhibits ovicidal, larvicidal and vermicidal activity. Rediout Chewable Tablet 1's inhibits tubulin polymerisation, which causes metabolic disruption and energy depletion in the parasite. This leads to the immobilisation of the parasite. Thereby, Rediout Chewable Tablet 1's kills the susceptible helminth and treats the infection.
Rediout Chewable Tablet 1's causes metabolic disruption and energy depletion in the parasite, which leads to its immobilisation. Thereby, Rediout Chewable Tablet 1's kills the susceptible helminth and treats the infection.
For neurocysticercosis, Rediout Chewable Tablet 1's is usually prescribed for 8-30 days. For cystic hydatid disease, Rediout Chewable Tablet 1's is usually prescribed for 28 days, followed by a 14 day break, and repeated for a total of 3 cycles.
Do not discontinue Rediout Chewable Tablet 1's without consulting your doctor. To treat your condition effectually continue taking Rediout Chewable Tablet 1's for as long as prescribed. Do not be reluctant to speak with your doctor if you feel any difficulty while taking Rediout Chewable Tablet 1's.
You are recommended to avoid planning for pregnancy while taking Rediout Chewable Tablet 1's as it may cause foetal harm. A pregnancy test should be done before starting the treatment with Rediout Chewable Tablet 1's, and women must use effective birth-control while taking Rediout Chewable Tablet 1's and for at least 1month after cessation of treatment.
Regular monitoring of blood count at the beginning of each cycle therapy and for every 2weeks while taking Rediout Chewable Tablet 1's is advised for all patients. Treatment with Rediout Chewable Tablet 1's should be discontinued if a significant decrease in blood cell count is observed.
Treatment with Rediout Chewable Tablet 1's has been associated with mild to moderate elevations of liver enzymes. These elevations generally return to normal upon discontinuation of Rediout Chewable Tablet 1's. Liver function tests should be performed before each treatment cycle and for every 2weeks during the treatment. Treatment with Rediout Chewable Tablet 1's should be discontinued if the liver enzymes exceed twice the upper limit of normal.
Rediout Chewable Tablet 1's might increase the chances of getting an infection. Maintain proper hygiene and try to stay away from people with infections, flu or cold.
You may bleed or bruise easily while taking Rediout Chewable Tablet 1's. Be cautious while using sharp objects and try to avoid injuries. Consult your doctor if you notice unusual bleeding or bruising.